Adjuvant chemotherapy in patients with recurrence after completely resected stage IB lung adenocarcinoma: Propensity‐matched analysis in a cohort of 147 recurrences (English)
Free access
- New search for: Xu, Fei
- New search for: Chen, Heng‐chi
- New search for: Xu, Haiyan
- New search for: Li, Junling
- New search for: Hao, Xuezhi
- New search for: Xing, Puyuan
- New search for: Ying, Jianming
- New search for: Wang, Yan
- New search for: Xu, Fei
- New search for: Chen, Heng‐chi
- New search for: Xu, Haiyan
- New search for: Li, Junling
- New search for: Hao, Xuezhi
- New search for: Xing, Puyuan
- New search for: Ying, Jianming
- New search for: Wang, Yan
In:
Thoracic Cancer
;
13
, 22
;
3105-3113
;
2022
- Article (Journal) / Electronic Resource
-
Title:Adjuvant chemotherapy in patients with recurrence after completely resected stage IB lung adenocarcinoma: Propensity‐matched analysis in a cohort of 147 recurrences
-
Contributors:Xu, Fei ( author ) / Chen, Heng‐chi ( author ) / Xu, Haiyan ( author ) / Li, Junling ( author ) / Hao, Xuezhi ( author ) / Xing, Puyuan ( author ) / Ying, Jianming ( author ) / Wang, Yan ( author )
-
Published in:Thoracic Cancer ; 13, 22 ; 3105-3113
-
Publisher:
- New search for: John Wiley & Sons Australia, Ltd
-
Publication date:2022-11-01
-
Size:9 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Keywords:
-
Source:
Table of contents – Volume 13, Issue 22
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 3103
-
Issue Information| 2022
- 3105
-
Adjuvant chemotherapy in patients with recurrence after completely resected stage IB lung adenocarcinoma: Propensity‐matched analysis in a cohort of 147 recurrencesXu, Fei / Chen, Heng‐chi / Xu, Haiyan / Li, Junling / Hao, Xuezhi / Xing, Puyuan / Ying, Jianming / Wang, Yan et al. | 2022
- 3114
-
Integrating 18F‐FDG PET/CT with lung dose‐volume for assessing lung inflammatory changes after arc‐based radiotherapy for esophageal cancer: A pilot studyHsu, Chen‐Xiong / Lin, Kuan‐Heng / Shueng, Pei‐Wei / Wu, Yen‐Wen / Tsai, Wei‐Ta / Chang, Chiu‐Han / Tien, Hui‐Ju / Wang, Shan‐Ying / Wu, Tung‐Hsin / Mok, Greta S. P. et al. | 2022
- 3124
-
Immunotherapy combined with chemotherapy versus chemotherapy alone as the first‐line treatment of PD‐L1‐negative and driver‐gene‐negative advanced nonsquamous non‐small‐cell lung cancer: An updated systematic review and meta‐analysisChai, Yue / Wu, Xinyu / Zou, Yifeng / Zhang, Xue / Bai, Hua / Dong, Mei / Duan, Jianchun et al. | 2022
- 3133
-
Circ‐EIF3I facilitates proliferation, migration, and invasion of lung cancer via regulating the activity of Wnt/β‐catenin pathway through the miR‐1253/NOVA2 axisChen, Tao / Feng, Guangqiang / Xing, Zhisong / Gao, Xingcai et al. | 2022
- 3145
-
Comparison of ultrasound and mammography for early diagnosis of breast cancer among Chinese women with suspected breast lesions: A prospective trialWang, Yingjiao / Li, Yuechong / Song, Yu / Chen, Chang / Wang, Zhe / Li, Linrong / Liu, Mohan / Liu, Guanmo / Xu, Yali / Zhou, Yidong et al. | 2022
- 3152
-
Real‐world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non‐small cell lung cancerHuang, Yiqing / Zhao, Joseph J. / Soon, Yu Yang / Wong, Alvin / Aminkeng, Folefac / Ang, Yvonne / Asokumaran, Yugarajah / Low, Jia Li / Lee, Matilda / Choo, Joan R. E. et al. | 2022
- 3162
-
Predictive value of early kinetics of ctDNA combined with cfDNA and serum CEA for EGFR‐TKI treatment in advanced non‐small cell lung cancerZheng, Jie / Wang, Yubo / Hu, Chen / Zhu, Mengxiao / Ii, Jianghua / Lin, Caiyu / Lu, Conghua / Dou, Yuanyao / Zhao, Chenlong / Zhang, Yimin et al. | 2022
- 3174
-
Sublobectomy for stage IA1‐2 invasive lung adenocarcinoma with consolidation tumor ratio ≤ 0.25Qi, Yi‐Fan / Qiu, Zhen‐Bin / Zhang, Chao / Fu, Rui / Yang, Xiong‐Wen / Chu, Xiang‐Peng / Chen, Zi‐Hao / Yang, Xue‐Ning / Wu, Yi‐Long / Zhong, Wen‐Zhao et al. | 2022
- 3183
-
Noninvasive assessment of breast cancer molecular subtypes on multiparametric MRI using convolutional neural network with transfer learningYin, Haolin / Bai, Lutian / Jia, Huihui / Lin, Guangwu et al. | 2022
- 3192
-
Patient‐reported outcomes of laryngeal mask anesthesia in thoracoscopic pulmonary wedge resection: A randomized controlled studyXu, Kaikai / Zhang, Yi / Cui, Yong / Tian, Feng et al. | 2022
- 3200
-
Coronavirus disease 2019 (COVID‐19) in patients before, during, or after lung irradiation, and serum SP‐A and SP‐D levelsIshibashi, Naoya / Maebayashi, Toshiya / Aizawa, Takuya / Sakaguchi, Masakuni / Okada, Masahiro et al. | 2022
- 3208
-
Pathologic responses to neoadjuvant chemoimmunotherapy in primary limited‐stage small‐cell lung cancerLu, Meng / Zhang, Ran / Qi, Li‐sha / Wang, Ya‐lei / Sun, Xiao‐xuan / You, Jian et al. | 2022
- 3217
-
Comparison of next‐generation sequencing and cobas EGFR mutation test v2 in detecting EGFR mutationsMurakami, Shuji / Yokose, Tomoyuki / Shinada, Kanako / Isaka, Testuya / Katakura, Kengo / Ushio, Ryouta / Kondo, Tetsuro / Kato, Terufumi / Ito, Hiroyuki / Saito, Haruhiro et al. | 2022
- 3225
-
Durable response to afatinib rechallenge in a long‐term survivor of non‐small cell lung cancer harboring EGFR L858R and L747V mutationsKanbe, Mio / Sunaga, Noriaki / Hara, Kenichiro / Sawada, Hiiru / Wakamatsu, Ikuo / Hara, Kentaro / Muto, Sohei / Sawada, Yuri / Masubuchi, Hiroaki / Sato, Mari et al. | 2022
- 3229
-
Clinicopathological analysis of a superior sulcus tumor treated by salvage surgery after concurrent definitive chemoradiotherapy followed by durvalumab: A case reportFunaki, Soichiro / Ose, Naoko / Kimura, Toru / Kanou, Takashi / Fukui, Eriko / Shintani, Yasushi et al. | 2022
- 3233
-
Nodule‐type pneumonitis mimicking lung abscess or tumor recurrence on chest computed tomography identified as osimertinib‐induced pneumonitis: A case reportOtsuki, Ayumu / Homma, Yuya / Yoshimi, Michinori / Ito, Hiroyuki / Nakashima, Kei et al. | 2022